Ditchcarbon
  • Contact
  1. Organizations
  2. Daiichi Sankyo
Public Profile
Medical Device Manufacturing
JP
updated a month ago

Daiichi Sankyo

Company website

Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical firm headquartered in Tokyo, Japan. Founded in 1899, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative healthcare solutions. Specialising in the research, development, and manufacturing of pharmaceuticals, Daiichi Sankyo is particularly renowned for its contributions to oncology, cardiovascular, and vaccine development. The company’s unique approach combines cutting-edge science with a commitment to improving patient outcomes, positioning it as a leader in the pharmaceutical industry. With a rich history marked by key milestones, Daiichi Sankyo has achieved notable success, including the development of groundbreaking therapies that have transformed treatment paradigms. Its dedication to innovation and quality has solidified its reputation as a trusted name in healthcare worldwide.

DitchCarbon Score

How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

67

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Daiichi Sankyo's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

81%

Let us know if this data was useful to you

Daiichi Sankyo's reported carbon emissions

In 2024, Daiichi Sankyo reported total carbon emissions of approximately 4,274,477,000 kg CO2e, with Scope 1 emissions at about 89,118,000 kg CO2e, Scope 2 emissions at approximately 24,888,000 kg CO2e, and a significant Scope 3 contribution of around 4,160,471,000 kg CO2e. The company's emissions for 2023 were approximately 4,517,975,000 kg CO2e globally, with Scope 1 at about 85,245,000 kg CO2e and Scope 2 at approximately 23,994,000 kg CO2e. Daiichi Sankyo has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions by FY2050. This long-term target encompasses all scopes of emissions. In the near term, the company has committed to reducing absolute Scope 1 and 2 GHG emissions by 63% by FY2030 from a FY2015 baseline. Additionally, they plan to increase their sourcing of renewable electricity from 4% in FY2015 to 100% by FY2030. Furthermore, they aim for 70.6% of their suppliers, by emissions, to have science-based targets by FY2025. These targets are part of Daiichi Sankyo's broader sustainability strategy, which aligns with the Science Based Targets initiative (SBTi) and reflects their commitment to responsible corporate practices in addressing climate change.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20112012201320142015201620172018201920202021202220232024
Scope 1
182,519,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
290,715,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
5,704,000
-
-
-
-
-
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Daiichi Sankyo's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Daiichi Sankyo is in JP, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Daiichi Sankyo is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

TG Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

OSE Immunotherapeutics SA

FR
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Endo Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251018.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy